2016 Bridging Biomedical Worlds Conference

Frontiers in Human Microbiota Symbiotic Interactions

May 23-25, 2016, Hong-Kong

“Frontiers in Human Microbiota Symbiotic Interactions” was held in Hong Kong, May 23-25, 2016 and was jointly organized by Fondation IPSEN, AAAS/Science and AAAS/Science Translational Medicine, and the University of Hong Kong.
Human beings, in common with most living creatures, are supraorganisms colonized by a huge diversity of bacteria and viruses, our microbiota. In 2016, the meeting was hold in Hong Kong, brought together an international roster of top scientists working at the interface of the microbiota and the hosts it inhabits. Talks will highlight exciting research in the fields of immunology, microbiology, ecology and evolution, and metabolism. Participants learned about how the microbiota shapes the host immune response and how alterations to the microbiota through infection, medication or diet can influence susceptibility to a variety of diseases. An expert panel discussed the challenges of big data in microbiome research and proposed solutions. In the final session, thought leaders discussed the translational implications of this burgeoning field and the challenges that lie ahead.

Invited Speakers

CERF-BENSUSSAN Nadine

Laboratoire d’Immunité Intestinale, Inserm UMRS1163 – Institut Imagine – Université Paris Descartes
Paris, France

ELINAV Eran

Department of Immunology, Weizmann Institute of Science

Rehovot, Israel

GAJEWSKI Thomas F.

DThe Ben May Department for Cancer, University of Chicago

Chicago, USA

GILBERT Jack A.

Department of Surgery, University of Chicago

Chicago, USA

HENRY Amanda

Plant Foods in Hominin Dietary Ecology Group, Max Planck Institute for Evolutionary Anthropology

Leipzig, Germany

HILL Colin

APC Microbiome Institute, University College Cork

Cork, Ireland

HOLMES Elaine

Division of Computational and Systems Medicine, Department of Surgery and Cancer, Imperial College London

London, UK

LITTMAN Dan

Department of Molecular Immunology, New York University Medical Center

New York, USA

MARTIN François-Pierre J.

Molecular Biomarkers, Nestlé Institute of Health Sciences

Lausanne, Switzerland

MARTIN François-Pierre J.

Molecular Biomarkers, Nestlé Institute of Health Sciences

Lausanne, Switzerland

MAZMANIAN Sarkis K.

Division of Biology and Biological Engineering, California Institute of Technology

Pasadena, USA

MCFALL-NGAI Margaret J.

Pacific Biosciences Research Center, University of Hawai‘i at Manoa
Honolulu, USA

OHTANI Naoko

Department of Applied Biological Science, Tokyo University of Science
Chiba, Japan

PALM Noah W.

Department of Immunobiology, Yale University School of Medicine
New Haven, USA

PAMER Eric G.

Infectious Diseases Service, Memorial Sloan Kettering Cancer Center
New York, USA

PETTERSSON Sven

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet
Stockholm, Sweden

SANSONETTI Philippe J.

Collège de France, and Pathogénie Microbienne Moléculaire – Inserm U1202, Institut Pasteur
Paris, France

SASSONE-CORSI Paolo

Center for Epigenetics and Metabolism, University of California, Irvine
Irvine, USA

Irvine, USA

WOO Connie W.H.

Department of Pharmacology & Pharmacy,
Hong Kong, China

ZITVOGEL Laurence

Immunologie des Tumeurs et Immunothérapie, Inserm U1015
Villejuif, France